Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 by in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades Continue reading “Selecting Anti-Melanoma Drug Targets” »

Immune Checkpoints: New Promises in Cancer Treatment

Posted on October 26th, 2016 by in Pharma R&D

Cancer immunotherapy (especially checkpoint inhibitors) is hot in the cancer therapeutics world, but we are still learning about how best to use them and in which patients. The current explosion in new cancer immunotherapies relates to braking T-cell activation: checkpoint therapies. Continue reading “Immune Checkpoints: New Promises in Cancer Treatment” »